Novo Nordisk President & CEO Mike Doustdar discusses the recent US approval of Novo Nordisk's Wegovy weight loss pill, the advantage of being the first to market, the availability of the pill, the company's gameplan, and the timeline of the pill's release. Doustdar spoke with Bloomberg's Katie Greifeld.

Airbnb CEO Brian Chesky Talks Car Rentals, Food, Hotels
05:56

Hasbro CEO Chris Cocks Talks Oil Costs, Video Games
09:06

Joe Lavorgna Talks US Economy, Bond Market
14:34